214 related articles for article (PubMed ID: 1627572)
1. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
[TBL] [Abstract][Full Text] [Related]
4. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
[TBL] [Abstract][Full Text] [Related]
5. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis.
Hervio L; Durlach V; Girard-Globa A; Anglés-Cano E
Biochemistry; 1995 Oct; 34(41):13353-8. PubMed ID: 7577920
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
Sangrar W; Koschinsky ML
Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
[TBL] [Abstract][Full Text] [Related]
7. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
8. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
11. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the N-terminal and C-terminal domains of human apolipoprotein(a): relevance to fibrin binding.
Huby T; Schröder W; Doucet C; Chapman J; Thillet J
Biochemistry; 1995 Jun; 34(22):7385-93. PubMed ID: 7779780
[TBL] [Abstract][Full Text] [Related]
14. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
15. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.
Anglés-Cano E
Chem Phys Lipids; 1994 Jan; 67-68():353-62. PubMed ID: 8187235
[TBL] [Abstract][Full Text] [Related]
16. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
[TBL] [Abstract][Full Text] [Related]
17. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
Hervio L; Chapman MJ; Thillet J; Loyau S; Anglés-Cano E
Blood; 1993 Jul; 82(2):392-7. PubMed ID: 8329699
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.
Fleury V; Anglés-Cano E
Biochemistry; 1991 Jul; 30(30):7630-8. PubMed ID: 1677272
[TBL] [Abstract][Full Text] [Related]
19. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
Klezovitch O; Edelstein C; Scanu AM
J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
